- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SANUWAVE HEALTH Aktie jetzt für 0€ handeln | |||||
| 08.12.25 | Sanuwave: UltraMIST-System in Einkaufsnetzwerk von Healogics aufgenommen | 2 | Investing.com Deutsch | ||
| 08.12.25 | Sanuwave's UltraMIST added to Healogics iSupply purchasing network | 2 | Investing.com | ||
| 08.12.25 | SANUWAVE Health, Inc.: Sanuwave Announces the Addition of UltraMIST to Healogics Group Purchasing Organization (GPO), iSupply | 1 | GlobeNewswire (USA) | ||
| 07.11.25 | SANUWAVE targets $13M-$14M Q4 revenue while leveraging post-CMS rule clarity | 2 | Seeking Alpha | ||
| 07.11.25 | SANUWAVE Health GAAP EPS of $0.46 beats by $0.14, revenue of $11.5M beats by $0.07M | 1 | Seeking Alpha | ||
| 07.11.25 | SANUWAVE Health, Inc.: Sanuwave Announces Q3 FY2025 Financial Results | 126 | GlobeNewswire (Europe) | Q3 2025 revenues were $11.5 million, up 22% from $9.4 million in Q3 2024. This represents the highest quarterly revenues in Company history. Q3 2025 gross margin was 77.9%, versus 75.5% in Q3 2024.... ► Artikel lesen | |
| 07.11.25 | SANUWAVE Health, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 06.11.25 | SANUWAVE Health, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 05.11.25 | An Overview of SANUWAVE Health's Earnings | 1 | Benzinga.com | ||
| 03.11.25 | SANUWAVE Health, Inc.: CMS Publishes Final Rule for Calendar Year 2026 Physician Fee Schedule for UltraMIST Procedure (CPT code 97610) | 4 | GlobeNewswire (USA) | ||
| 30.10.25 | SANUWAVE Health, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 06.10.25 | Sanuwave reports record quarterly revenue of $11.4-11.6 million | 1 | Investing.com | ||
| 06.10.25 | Sanuwave Health expects Q3 revenue between $11.4M and $11.6M | 1 | Seeking Alpha | ||
| 06.10.25 | SANUWAVE Health, Inc.: Sanuwave Health Announces Preliminary Revenue Results for the Third Quarter 2025 (Ended September 30, 2025) | 138 | GlobeNewswire (Europe) | Sanuwave announces preliminary revenues of $11.4 million to $11.6 million for the third quarter ended September 30, 2025. This represents the highest quarterly revenues in Company history. Q3 2025... ► Artikel lesen | |
| 01.10.25 | Sanuwave Health baut Führungsebene um: Daniel Coyle wird neuer Chief Operating Officer | 1 | Investing.com Deutsch | ||
| 30.09.25 | Sanuwave Health is a buy, this analyst says | 1 | Cantech Letter | ||
| 26.09.25 | SANUWAVE Health, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 26.09.25 | Sanuwave refinances debt with new credit facility | 1 | Seeking Alpha | ||
| 26.09.25 | Sanuwave Health refinances $27.5 million debt with J.P. Morgan facility | 3 | Investing.com | ||
| 26.09.25 | SANUWAVE Health, Inc.: Sanuwave Announces Strategic Debt Refinancing with New Credit Facility | 782 | GlobeNewswire (Europe) | Credit facility from J.P. Morgan consists of a four-year term loan of $23 million and a two-year $5 million revolving credit facility backed by accounts receivable Both the term loan and revolver... ► Artikel lesen |
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,530 | +0,48 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,010 | -0,43 % | EILMELDUNG: Fresenius Medical Care-Aktie bricht ein - Panik greift um sich! | ||
| FRESENIUS | 49,750 | +1,59 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| LUMEXA IMAGING | 17,730 | +2,37 % | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO | ||
| ALIGNMENT HEALTHCARE | 20,950 | 0,00 % | Where Alignment Healthcare Stands With Analysts | ||
| BRIGHTSPRING HEALTH SERVICES | 39,080 | 0,00 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| BETA BIONICS | 31,990 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | ||
| PROCEPT BIOROBOTICS | 34,480 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HEARTFLOW | 33,470 | 0,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,680 | -2,25 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| PROGYNY | 27,440 | 0,00 % | Progyny-Aktie: Truist Securities stuft auf 'Kaufen' hoch und verweist auf verbesserte Aussichten | ||
| ECKERT & ZIEGLER | 15,410 | -2,41 % | Eckert & Ziegler - Kurzbericht zur Aktienentwicklung | ||
| MIMEDX | 6,310 | -2,02 % | MiMedx Group, Inc: MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit-Wound Gel | MARIETTA, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced it has entered into an exclusive agreement with Regen Lab USA LLC to... ► Artikel lesen | |
| NEUROPACE | 16,960 | +0,89 % | BDMD: Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion | NEW YORK, Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive... ► Artikel lesen | |
| BILLIONTOONE | 87,59 | 0,00 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen |
SANUWAVE HEALTH INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,220 (+0,72 %) liegt der Kurs bei 30,600 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SANUWAVE HEALTH INC finden Sie auf Wallstreet Online.